Estonian biotechnology company Icosagen has completed a €45 million expansion [...]

Poolbeg Pharma has secured a South African patent covering the [...]

Grifols has dosed the first participant in a Phase 3 [...]

Genoskin is expanding its US operations with a new laboratory [...]

Resalis Therapeutics has dosed the first participant in a Phase [...]

Hemab Therapeutics has highlighted new clinical and preclinical data across [...]

Adults with epilepsy and hearing loss who use hearing aids [...]

BridgeBio has published results from its pivotal Phase 3 Propel [...]

BioInnovation Institute has opened its first international base in London [...]

The European Commission has granted orphan drug designation to Chiesi [...]